The bispecific antibody ATG-101, an anti-PD-L1 IgG1 molecule linked with two anti-4-1BB scFV molecules, has been developed and demonstrated potent anti-tumour efficacy in various preclinical models [24]. The gene discussed is CD274; the disease is neoplasm.